Spandidos Publications style
Ibrahim T, Liverani C, Mercatali L, Sacanna E, Zanoni M, Fabbri F, Zoli W and Amadori D: [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines. Int J Oncol 49: 1260-1260, 2016
APA
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F. ... Amadori, D. (2016). [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines. International Journal of Oncology, 49, 1260-1260. https://doi.org/10.3892/ijo.2016.3613
MLA
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F., Zoli, W., Amadori, D."[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines". International Journal of Oncology 49.3 (2016): 1260-1260.
Chicago
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F., Zoli, W., Amadori, D."[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines". International Journal of Oncology 49, no. 3 (2016): 1260-1260. https://doi.org/10.3892/ijo.2016.3613